Denali Advisors LLC Reduces Stake in Cabot Corporation $CBT

Denali Advisors LLC lessened its holdings in shares of Cabot Corporation (NYSE:CBT) by 18.9% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 86,707 shares of the specialty chemicals company’s stock after selling 20,212 shares during the period. Denali Advisors LLC’s holdings in Cabot were worth $7,875,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. Torren Management LLC acquired a new position in Cabot in the fourth quarter valued at approximately $26,000. Rothschild Investment LLC raised its holdings in Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 259 shares in the last quarter. Geneos Wealth Management Inc. lifted its position in shares of Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares during the last quarter. Global Retirement Partners LLC lifted its position in shares of Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after buying an additional 466 shares during the last quarter. Finally, Danske Bank A S acquired a new position in shares of Cabot in the 3rd quarter valued at $38,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. UBS Group cut their price target on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 5th. JPMorgan Chase & Co. upped their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research note on Friday, August 7th. Truist Financial set a $100.00 price objective on Cabot in a report on Wednesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Finally, Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Cabot presently has an average rating of “Hold” and an average target price of $89.00.

Cabot Price Performance

Shares of NYSE:CBT opened at $85.34 on Thursday. Cabot Corporation has a one year low of $58.33 and a one year high of $94.53. The stock has a market capitalization of $4.41 billion, a price-to-earnings ratio of 24.04, a PEG ratio of 10.99 and a beta of 0.84. The company has a 50-day simple moving average of $88.23 and a 200-day simple moving average of $80.75. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. The firm had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The business’s revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the company posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, analysts predict that Cabot Corporation will post 6.33 EPS for the current year.

Cabot Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a $0.4725 dividend. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio (DPR) is 53.24%.

Insider Activity

In other news, CEO Sean D. Keohane sold 91,923 shares of the company’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the completion of the sale, the chief executive officer owned 404,134 shares in the company, valued at $34,921,218.94. This represents a 18.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 3.08% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.